Knee Osteoarthritis Study Shows Promising Results with Lipogems® Treatment

Nima Heidari, Ali Noorani, Mark Slevin, Angela Cullen, Laura Stark, Stefano Olgiati, Alberto Zerbi, Adrian Wilson · BioMed Research International · 2020

110 Knees Treated in Year-Long UK Observational Study

Researchers at The Regenerative Clinic in London tracked 110 knees treated with a single injection of micro-fragmented adipose tissue (MFAT). MFAT is specially processed fat tissue from your own body that contains regenerative cells. This study followed patients for twelve months to measure changes in pain, daily function, and quality of life. All patients had confirmed knee osteoarthritis diagnosed through X-rays and MRI scans.

Pain Scores Cut by More Than Half on Average

The study measured pain using a standard 0-100 scale, where higher numbers mean worse pain. Before treatment, patients reported a median pain score of 70. At twelve months, this dropped to 30—a reduction of more than half. This improvement was statistically significant, meaning it was very unlikely to have occurred by chance. For many patients, this level of pain reduction can mean the difference between struggling with daily tasks and returning to normal activities.

Knee Function Improved Significantly After Treatment

Researchers used the Oxford Knee Score to measure how well patients could perform everyday activities. This test asks about tasks like:

  • Walking and climbing stairs

  • Getting in and out of chairs

  • Pain during daily activities

  • Sleep quality affected by knee pain

Scores improved from a median of 25 before treatment to 33.5 at twelve months. Higher scores indicate better function. This nine-point improvement represents meaningful gains in patients' ability to move and live without knee limitations.

Quality of Life Gains Reported Across the Board

The study also tracked overall quality of life using a widely respected health questionnaire (EQ-5D). Scores improved from 0.62 to 0.69, showing that patients felt better overall—not just in their knees. This matters because chronic knee pain affects sleep, mood, and the ability to enjoy life. All three measurements—pain, function, and quality of life—showed statistically significant improvements.

Zero Adverse Events Reported During Entire Study

Perhaps most reassuring for patients considering this treatment: no adverse events occurred. Researchers monitored patients during the procedure, during recovery, and throughout the twelve-month follow-up period. No complications were reported at any stage. This safety profile aligns with the nature of the treatment—using your own tissue means there is no risk of rejection or allergic reaction.

All Grades of Osteoarthritis Showed Improvement

The study included patients with varying severity of knee osteoarthritis, classified using a standard grading system. Importantly, patients across all grades experienced benefits. This suggests that Lipogems® may help whether your arthritis is mild or more advanced. However, researchers note that further studies would help confirm these encouraging results and better understand which patients respond best.

---

What This Means for You: This study adds to growing evidence that a single injection of your own processed fat tissue can meaningfully reduce knee pain and improve daily function. The treatment showed strong results with no reported side effects. While this was an observational study rather than a randomized trial, the consistent improvements across 110 knees over twelve months are encouraging for patients seeking alternatives to surgery or ongoing medication.

Source: Heidari et al., BioMed Research International, 2020.

Original Publication

Patient-Centered Outcomes of Microfragmented Adipose Tissue Treatments of Knee Osteoarthritis: An Observational, Intention-to-Treat Study at Twelve Months

Nima Heidari, Ali Noorani, Mark Slevin, Angela Cullen, Laura Stark, Stefano Olgiati, Alberto Zerbi, Adrian Wilson · BioMed Research International · 2020

This observational, intention-to-treat study assessed patient-centered outcomes of microfragmented adipose tissue (MFAT) treatment for knee osteoarthritis in 110 knees over twelve months. Patients with VAS > 50 and radiographically confirmed knee osteoarthritis received a single ultrasound-guided intra-articular injection of autologous MFAT. Exclusion criteria included recent knee injury (< 3 months), recent steroid injections, and prior hyaluronic acid treatment. Outcomes were measured using Visual Analog Scale (VAS) for pain, Oxford Knee Score (OKS) for function, and EQ-5D for quality of life at baseline and twelve months post-injection. Data were analyzed using nonparametric paired samples Wilcoxon test. Results demonstrated statistically significant improvements across all measures: median VAS improved from 70 (IQR 20) to 30 (IQR 58) (p < 0.001); median OKS improved from 25 (IQR 11) to 33.5 (IQR 16) (p < 0.001); and median EQ-5D improved from 0.62 (IQR 0.41) to 0.69 (IQR 0.28) (p < 0.001). No adverse events were reported during any treatment phase. The findings suggest intra-articular MFAT injection significantly improves pain, function, and quality of life in patients with all grades of knee osteoarthritis, though further research is warranted to confirm these encouraging results.

Related Research